FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Reg. 30 of SEBI LODR, please find enclosed herewith the Press Release and earning presentation for the quarter ended June 30, 2023. FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') In Relation To Initiation Of The Proposed Initial Public Offer By Way Of Offer For Sale, By Agilus Diagnostics Limited ('Agilus'), A Material Subsidiary Of The Fortis Healthcare Limited ('Company')
Pursuant to regulation 30 of SEBI LODR and in furtherance of the Contractual obligations contained in Shareholders Agreement executed on June 12, 2012(as amended vide amendment agreement dated March 30, 2021) as previously disclosed , this is to inform you that the Board of Directors of the Company and the Board of Directors of the Agilus Diagnostics Limited, in their respective meetings held today i.e. August 4, 2023, have considered and granted its confirmation/approval for Agilus to initiate an Initial Public Offer process, by way of offer of sale. The detailed disclosures in this regard is enclosed herewith. FORTIS HEALTHCARE LTD. - 532843 - Un-Audited Results For The Quarter Ended June 30, 2023
Pursuant to Regulation 30 of SEBI LODR, please find enclosed un-audited standalone and consolidated financial results for the quarter ended June 30, 2023 FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Outcome for Outcome Of Board Meeting-Approval Of Un-Audited Financial Results For Quarter Ended June 30, 2023
Pursuant to reg. 30 of SEBI LODR, please find enclosed un-audited standalone and consolidated financial results for the quarter ended June 30, 2023. FORTIS HEALTHCARE LTD. - 532843 - Submission Of Details Regarding Voting Results Of The 27Th Annual General Meeting Under Regulation 44 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Fortis Healthcare Limited has submitted the voting results of the 27th Annual General Meeting held on August 1, 2023 alongwith Scrutinizer''s Report. FORTIS HEALTHCARE LTD. - 532843 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Fortis Healthcare Limited has submitted the voting results of the 27th Annual General Meeting held on August 1, 2023 along with Scrutinizer''s Report. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of upcoming conference call invite to discuss the Company's un-audited financial results for the quarter ended June 30, 2023: Date & Time August 7, 2023 at 11:00 A.M. (IST) Investors / Analysts / Events: Q1FY24 Post Results Conference Call Invite. Location: Virtual Conference Please find enclosed herewith dial-in numbers alongwith participation link. No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investors / analysts' meet. FORTIS HEALTHCARE LTD. - 532843 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of 27th Annual General Meeting of Fortis Healthcare Limited held on Tuesday, August 1, 2023. FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, August 4, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2023. Further, in continuation to our letter ref. FHL/SEC/2023-24 dated June 29, 2023 captioned 'Closure of Trading Window', it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 6, 2023. FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of Fortis Hospitals Limited (a material subsidiary of the Company), in its meeting held today i.e. July 27, 2023, has, subject to approval of National Company Law Tribunal or any other relevant authority, approved this intra group restructuring involving entities that are directly/indirectly 100% owned by the Company, by way of a ''Composite Scheme of Arrangement''. Please find enclosed detailed disclosure in this regard.